The optimized formulation has a long shelf life and is completely free of interference due to sample turbidity
There have been post-marketing reports of acute kidney injury, some requiring hospitalization and dialysis, in patients with type 2 diabetes mellitus receiving SGLT2 inhibitors, including JARDIANCE
Clinical trial data and post-marketing surveillance have documented gastrointestinal complaints in a substantial proportion of patients, with nausea being the most frequent (reported in 1540% of patients depending on the specific agent and dose), followed by vomiting, diarrhoea, constipation, and dyspepsia
Meet Michael The War and Treaty A Day in My Ozempic Era Maria Maria is a proud entrepreneur and salon owner living with type 2 diabetes and makes it a priority to find the best treatment plan for her
Revolutionary Pelvic Health Strengthen Your Core with EmsellA Redefine comfort and confidence with Emsella, a revolutionary treatment targeting pelvic muscles